ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LMT Lombard Med.Tec

188.50
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Lombard Med.Tec LSE:LMT London Ordinary Share GB00B7FT8W85 ORD 20P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 188.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Lombard Medical Technologies Share Discussion Threads

Showing 1376 to 1400 of 2025 messages
Chat Pages: Latest  57  56  55  54  53  52  51  50  49  48  47  46  Older
DateSubjectAuthorDiscuss
12/1/2011
20:57
so i wonder what's going on, not that i am complaining!
webshares
12/1/2011
20:17
SP continuing to climb ...nice...now 124% up on my outlay...wished I'd bought alot more...seems there's tons of potential here! (imho, dyor)
rcktmn
12/1/2011
20:03
wahay. 50% up for me presently and this is potentially is the beginning.

i hope no one is tempted to sell.

webshares
12/1/2011
19:11
Hi Rayrac when Aorfix is approved in the US the market for stent grafts could potentially grow from $500m to $600m because Aorfix will be able to treat a group of patients who are untreatable with the devices currently approved. It is estimated the market size of this group is $100m. And of course only Aorfix will be approved for this group of patients with tortuous anatomies and will have this $100m segment exclusively. On top of that Aorfix will also be able to compete very effectively for a slice of the $500m market. This is the true excitement behind LMT and Aorfix - having the only product which can exclusively treat a large group of patients without competitors.
tctmeeting
12/1/2011
15:08
At times like this I always find myself wishing I had nought more!

This is defiantely the long game with this one, always has one, however it seems the 'end game' maybe be closer than a lot of people expected - I wasn't expecting this to rocket until at least mid 2011.

But yeah, bags of potential, focused on their product, delivered many cost savings, and are well funded up to product launch I believe.

Am I topping up at this point - probably not, if I had spare cash without having to sell other investments, yes, probably would.

munkychunky
12/1/2011
13:35
This co is ripe to be swallowed up by a larger player.
restassured
12/1/2011
12:15
Im showing as a sell, but of course, if you look at the trade time, it was a buy.
rayrac
12/1/2011
11:55
Meant $500m john. I'm well aware of what's what with this share, having been here for many years, including the previous incarnation!
rayrac
12/1/2011
11:46
$500 million rayrac not $500 thousand.

The US is the largest market for AAA stent grafts, worth over $500 million and we remain confident of achieving approval for Aorfix™ in this important market."

johnyee 7
12/1/2011
11:34
Could be somethings going to be announced.
philo124
12/1/2011
11:30
My feelings too jab.

I think they mention the US mkt alone is worth $500m and I think they mention double that in world total.

rayrac
12/1/2011
11:18
1 million buy just went through at 2.04.
johnyee 7
12/1/2011
11:16
On to 3p and beyond
restassured
12/1/2011
11:03
Over 2p !!
philo124
12/1/2011
10:58
Rayrac. by the looks of it, someone seems to be hovering up all the stock on this rise, could get exciting here.
jab118
12/1/2011
10:38
Probably get taken out by J&J, if they think a $500m market is worth it.
rayrac
12/1/2011
10:34
Just bought 10x that on line, just a tester. :)
rayrac
12/1/2011
10:29
10k?!

I doubt it.:)

rayrac
12/1/2011
10:21
is this the rise that all have been waiting for.can only get 10k online.
johnyee 7
12/1/2011
09:50
The buying this morning is no longer from the shares mag tip,I think we have a little gem here
balcony
12/1/2011
09:42
Nice buys going through.
johnyee 7
11/1/2011
20:04
There's certainly been a change in investor interest since the RNS on 13 December announcing the filing of the fifth FDA module and the postive update re its 2011 schedule:

"We set out clear timelines for submission of the PMA modules required for FDA
approval of Aorfix(TM) earlier this year and we remain firmly on track to
achieve them. We look forward to submitting the final PMA module demonstrating
the clinical evidence for the use of the Aorfix(TM) stent graft in the treatment of complex tortuous anatomy during the first half of 2011. The US is the largest market for AAA stent grafts, worth over $500 million, and we continue to be confident of winning approval for Aorfix(TM) in this important market."

nod
11/1/2011
12:42
happy to see a steady amount of volume though. needs a bit of news soonish to keep it up
webshares
11/1/2011
10:41
morning web,

looks most are holding, that's why we are moving up well on low volume ;-)

jab118
11/1/2011
08:41
its hard to put a price on this share but i would say 3p is a good start. what will the price be if and when it gets fda approval?? who knows. either way i'm holding
webshares
Chat Pages: Latest  57  56  55  54  53  52  51  50  49  48  47  46  Older

Your Recent History

Delayed Upgrade Clock